Developing targeted therapeutics for vascular barrier disorders
Developing targeted therapeutics for vascular barrier disorders
Signed in as:
filler@godaddy.com
Developing targeted therapeutics for vascular barrier disorders
Developing targeted therapeutics for vascular barrier disorders
Akttyva Therapeutics, Inc. is a National Science Foundation funded company founded by a team of pharmaceutical industry executives, scientists and entrepreneurs to develop targeted therapeutics for vascular leak disorders
To harness the understanding of biological pathways and to apply integrated artificial intelligence and in vitro/in vivo experiments on the structure of cell barriers so as to bring new therapies to patients
To develop innovative therapies addressing cell barrier dysfunction across multiple indications
Please reach out to us: +1-617-821-7095
241 Francis Avenue, Mansfield, MA 02048